Peripheral blood lymphocytes of a patient exposed to the SARS-CoV.
Alternative Names:
covid-19, sars-cov-2
Recombinant monoclonal antibody to SARS-CoV-2 Spike with variable regions (i.e., specificity) from the B-cell clone CR3022. Manufactured using a proprietary recombinant platform technology. On 31 December 2019, the World Health Organization (WHO) was ale